本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Acurx Pharmaceuticals, LLC*

1.40
0.0000
盤後1.400.0036+0.26%19:56 EDT
成交量:6.47萬
成交額:9.01萬
市值:765.98萬
市盈率:-0.46
高:1.41
開:1.41
低:1.38
收:1.40
52周最高:8.34
52周最低:1.31
股本:547.13萬
流通股本:534.27萬
量比:1.16
換手率:1.21%
股息:- -
股息率:- -
每股收益(TTM):-3.0454
每股收益(LYR):-5.3153
淨資產收益率:-128.11%
總資產收益率:-55.92%
市淨率:0.94
市盈率(LYR):-0.26

資料載入中...

2026/09/08

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/08

SEC問詢函

Form CORRESP - Correspondence
2026/05/08

SEC問詢函

Form CORRESP - Correspondence
2026/05/04

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/05/04

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/04/16

重要事件披露

Form 8-K - Current report
2026/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/09

重要事件披露

Form 8-K - Current report
2026/02/10

SEC問詢函

Form CORRESP - Correspondence
2026/02/02

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2026/01/02

SEC問詢函

Form CORRESP - Correspondence
2025/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/10/21

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/09/22

重要事件披露

Form 8-K - Current report
2025/09/19

重要事件披露

Form 8-K - Current report
2025/08/11

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/31

重要事件披露

Form 8-K - Current report